Today's Date: February 9, 2023
U.S. Air Force and SimX Expand Their VR Medical Training Partnership to $12 Million in R&D Funding   •   RENUVION® COSMETIC NECK LAXITY PROCEDURE TO BE FEATURED ON 'THE BALANCING ACT' TALK SHOW ON LIFETIME® FEBRUARY 13   •   Runway Growth Capital Announces a Senior Secured Term Loan of $50 Million to Madison Reed   •   SEEQC Partners With BASF To Explore Applications of Quantum Computing in Chemical Reactions for Industrial Use   •   The Music Lights the Way Piano Festival announces finalists chosen from nearly 8,000 participants   •   Lexington Clinic, Central Kentucky's Oldest and Largest Multi-Specialty Physician Group, Partners with agilon health to Introduc   •   AltPep Strengthens Advisory Board with Three Leading Experts in Alzheimer’s Disease and Neurodegenerative Disorders   •   The Wendy's Company Strengthens Commitment to Climate Action, Targeting Ambitious Greenhouse Gas Emissions Cuts   •   Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health   •   NYINI Luxury and Alnwick Castle 3PL Logistics Partner Together to Bring Powerhouse Marketing and Logistics to Luxury Brands   •   Elder Law Attorney Diane Weinberg Named to Super Lawyers List for 2023   •   Simulations Plus Releases Redesigned NAFLDsym® QSP Software Tool   •   The Sherwin-Williams Foundation and The Northeast Ohio Hispanic Center for Economic Development Expand Commitment   •   Charles River Laboratories Schedules Fourth-Quarter 2022 Earnings and 2023 Guidance Release and Conference Call   •   Dr. Mary McCluskey, CORE Team Up to Donate 'Bubbles, Balloons and Birds' Books to Ukrainians Affected by the War   •   GMED Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Globus Medical, Inc. Is Fair to Shareholders   •   TTA Joins AWS Training Partner Program to Deliver AWS Skills Training to IT Professionals in North America   •   Blue Earth Diagnostics Highlights Upcoming Presentation of Additional Results from Investigational Phase 3 LIGHTHOUSE Study of 1   •   TeamConnor Childhood Cancer Foundation Announces Grant Recipients in Pediatric Cancer Research for 2023   •   DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by the Veterans Health
Bookmark and Share

Flora Growth Forms JV With Avaria Health and Beauty to Distribute Award-Winning Pain Products Across LATAM

MIAMI & TORONTO , November 26 /Businesswire/ - Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is pleased to announce it has entered into a definitive agreement with Canada-based Avaria Health & Beauty Corp. (“Avaria”) to form FloVaria Corp. (“FloVaria”), a joint venture company equally owned by Flora and Avaria.

Through FloVaria, Flora will provide distribution, supply chain, and marketing support of KaLaya products in Colombia, Mexico, and other LATAM countries, while Avaria will initially supply the finished product to FloVaria. In the event that manufacturing costs from Canada become materially higher than the cost to produce in Colombia, FloVaria will explore moving its supply chain activities of Avaria products to Flora Lab. Any profits from the sale of KaLaya products via FloVaria will be divided equally between Flora and Avaria, increasing the value of Flora’s existing distribution channels.

Further, Flora Lab will work to produce FloVaria’s cannabinoid-infused products, with an emphasis on incorporating cannabidiol (“CBD”), using cannabis from Flora’s cultivation facility. These products are expected to be distributed across LATAM using Flora Lab’s established distribution channels, with the goal of exporting to the U.S. market, where Avaria recently launched its KaLaya brand and has seen encouraging sales metrics.

“Since our initial meeting with Avaria, we were impressed by their commitment to research, product development, and most importantly, providing customers with products that work,” said Luis Merchan, President and CEO of Flora Growth. “Avaria has achieved impressive and continued growth of its KaLaya brand based on the quality and efficacy of the product. Our team is very excited to bring their award-winning topical pain products to our LATAM distribution network, and to produce cannabinoid-infused KaLaya products at Flora Lab.”

“We believe that KaLaya products provide the best relief that you can get without a prescription,” said Dr. Keith Burk, M.D., founder and CEO of Avaria. “Our KaLaya pain cream brand has enjoyed strong success since inception and has garnered much consumer praise while receiving numerous industry awards. We’re incredibly excited to partner with Flora Growth to bring our award-winning KaLaya products to new international markets, and moreover, to produce cannabinoid-infused versions of these already established and highly efficacious products that our consumers have been demanding and looking forward to for some time now.”

KaLaya Observational Study on Pain Relief

A perception study with 48 volunteers was conducted by Avaria at Beechwood Clinic in Waterloo, Ontario, in 2019. These patients had acute and/or chronic medical conditions including arthritis, tendonitis, and joint pain, among others, and were asked to evaluate their experience of pain relief after application of KaLaya’s 6x Extra Strength Pain Relief.

The results showed that all volunteers felt improvement in pain or were free of pain within two minutes of application of K6XPR, where 52.1% felt pain relief within one minute. The average reduction in pain is 5 points on a 1-10 point pain score. Results indicate that K6XPR is an effective and efficient topical pain treatment for a variety of acute and chronic pain conditions.

About Flora Growth’s Recent Financing

Having received net proceeds of $31.5M from the recent closing of Flora’s public offering, the Company is well funded for growth as it continues to execute on its business initiatives including an expansion into the U.S. CBD market, a growth investment into recently acquired Vessel Brand, and an expansion into the newly legalized German adult-use cannabis market.

“Since our IPO in May of 2021, we have made substantial progress to expand our distribution network, launched new brands and brand partnerships, and closed or advanced multiple transactions. Looking forward, we expect to use this capital to amplify revenue growth from our operating divisions, identify and acquire new accretive M&A targets, and enter new markets like Germany’s newly formed adult-use cannabis market as legalization developments continue to unfold internationally,” commented Luis Merchan, Flora’s CEO.

About Avaria Health & Beauty Corp.

Privately owned and operated since 1995 by experienced medical professionals, Avaria Health & Beauty Corp., has over 20 years of experience in the formulation, manufacturing, and sale of topical creams, oils, emulsions, liquids, lotions, gels, and salves. Proudly Canadian, Avaria Health & Beauty Corp. is committed to maintaining its status as a 100% Canadian company. Research, development, and manufacturing takes place in Waterloo and Cambridge, Ontario. Avaria Health & Beauty Corp. brands enjoy distribution at all levels of retail and online, domestically, as well as in select international markets.

About Flora Growth Corp.

Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands that delivers the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit or follow @floragrowthcorp on social for more information.

Cautionary Statement Concerning Forward-Looking Statements

This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: the size of markets for cannabis and cannabis products; the expected performance of FloVaria; the impact of FloVaria on Flora’s business; the market for KaLaya products; Flora’s cultivation yields; Flora’s ability to sell cannabis and cannabis products to international markets; the collaboration with third parties; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.

STORY TAGS: Contract/Agreement, Product/Service, North America, United States, South America, Canada, Central America, Ontario, Florida, Other Health, Men, General Health, Discount/Variety, Specialty, Consumer, Convenience Store, Retail, Other Consumer, Women, Alternative Medicine, Health,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News